OTC Sanitizer Contaminations Drop In US As Auxiliary Manufacturers Stop Production
"Fewer people are manufacturing the products ... That seems to be a sort of a natural reaction to I think the decreased consumer demand," says Donald Ashley, compliance chief in FDA’s drug center.
You may also be interested in...
Tighter Testing New Normal For US OTC Sanitizer Firms Due To Contaminations During Pandemic
With higher demand a norm, OTC sanitizer firms should do the same with scrutiny of their supplies of alcohol and other ingredients. “The market itself will always be much higher than a pre-COVID level as it’s a consumer product that is going to be used on a more regular basis,” says Ed Wyszumiala, head of US Pharmacopeia’s verification program.
US FDA Testing Finds Consumer Health Market Problems, But It Can’t Test Entire Marketplace
CDER compliance office director Donald Ashley offers a cautionary note to temper expectations for the FDA’s enforcement in the supplement sector. “We continue to warn the public about products very often sold as dietary supplements that contain hidden drugs,” he says.
Trade Groups Push US FDA To Close Window On Loosened OTC Sanitizer Production Standards
A day after FDA posted Scentsational’s recall announcement due to presence of benzene and acetaldehyde as well as methanol, American Cleaning Institute and Consumer Healthcare Products Association submit a letter urging FDA to restore order to OTC alcohol-based sanitizer market.